Back to Journals » Drug Design, Development and Therapy » Volume 13

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways

Total article views   HTML views PDF downloads Totals
7,803 Dovepress* 6,300+ 1,009 7,309
PubMed Central* 1,503 402 1,905
Totals 7,803 1,411 9,214
*Since 2 December 2019

View citations on PubMed Central and Google Scholar